Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations-Reference-Cited by-同舟云学术

Pathologic chemotherapy response score in epithelial ovarian cancer: Surgical, genetic, and survival considerations

Published:2020-09 Issue: Volume:34 Page:40-45
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

Barrington David A.,Felix Ashley S.,Owda Rieham,Suarez Adrian A.,Cohen David W.,Senter Leigha,Copeland Larry J.,Fowler Jeffrey M.,Backes Floor J.,Cohn David E.,Bixel Kristin L.,O'Malley David M.,Salani Ritu,Cosgrove Casey M.

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference28 articles.

1. Cancer statistics;Siegel;CA Canc. J. Clin.,2019

2. Ovarian cancer statistics;Torre;CA Canc. J. Clin.,2018

3. Overall survival following neoadjuvant chemotherapy vs primary cytoreductive surgery in women with epithelial ovarian cancer: analysis of the national cancer database;Rauh-Hain;JAMA Oncol.,2017

4. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial;Kehoe;Lancet,2015

5. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N. Engl. J. Med.,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis;Pakistan Journal of Medical Sciences;2024-02-06

2. Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival;Gynecologic Oncology;2023-10

3. Association of Chemotherapy Response Score with Multidrug Resistance 1 and CA125 ELIMination Rate Constant K in Patients with Advanced Ovarian Cancer Treated with Neoadjuvant Chemotherapy;The Kurume Medical Journal;2023-06-30

4. BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score;International Journal of Gynecologic Cancer;2022-03-04

5. Prognostic Value of Chemotherapy Response Score (CRS) Assessed on the Adnexa in Ovarian High-Grade Serous Carcinoma: A Systematic Review and Meta-Analysis;Diagnostics;2022-03-04